Ignite Creation Date:
2024-05-05 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 9:52 AM
Study NCT ID:
NCT00718536
Status:
COMPLETED
Last Update Posted:
2019-12-05
First Post:
2008-07-16
Brief Title:
Clinical Trial Assessing Once Daily Raltegravir Administration 800 mg QD in HIV-1-Infected Patients Receiving Unboosted Atazanavir 400 mg QD- Based Antiretroviral Therapy
Sponsor:
Organization:
Germans Trias i Pujol Hospital